Author
Listed:
- Eitan Altman
(INRIA, Centre de Recherche de Sophia Antipolis-Mediterranee, 2004 Route des Lucioles, BP 93, 06902 Sophia Antipolis CEDEX, France
Laboratoire Informatique d’Avignon, Campus Jean-Henri Fabre, Avignon Universite, 84 911 Avignon, France
Laboratory of Information, Network and Communication Sciences, Avignon Universite, 75013 Paris, France)
- Izza Mounir
(Centre Hospitalier Universitaire de Nice, School of Medicine, Université Côte D’Azur, 30 Voie Romaine, 06000 Nice, France)
- Fatim-Zahra Najid
(Centre Hospitalier Universitaire Amiens Picardie, School of Medicine, Université de Picardie Jules Verne, 1 Rue du Professeur Christian Cabrol, 80054 Amiens, France)
- Samir M. Perlaza
(INRIA, Centre de Recherche de Sophia Antipolis-Mediterranee, 2004 Route des Lucioles, BP 93, 06902 Sophia Antipolis CEDEX, France)
Abstract
In this paper, a formula for estimating the prevalence ratio of a disease in a population that is tested with imperfect tests is given. The formula is in terms of the fraction of positive test results and test parameters, i.e., probability of true positives (sensitivity) and the probability of true negatives (specificity). The motivation of this work arises in the context of the COVID-19 pandemic in which estimating the number of infected individuals depends on the sensitivity and specificity of the tests. In this context, it is shown that approximating the prevalence ratio by the ratio between the number of positive tests and the total number of tested individuals leads to dramatically high estimation errors, and thus, unadapted public health policies. The relevance of estimating the prevalence ratio using the formula presented in this work is that precision increases with the number of tests. Two conclusions are drawn from this work. First, in order to ensure that a reliable estimation is achieved with a finite number of tests, testing campaigns must be implemented with tests for which the sum of the sensitivity and the specificity is sufficiently different than one. Second, the key parameter for reducing the estimation error is the number of tests. For a large number of tests, as long as the sum of the sensitivity and specificity is different than one, the exact values of these parameters have very little impact on the estimation error.
Suggested Citation
Eitan Altman & Izza Mounir & Fatim-Zahra Najid & Samir M. Perlaza, 2020.
"On the True Number of COVID-19 Infections: Effect of Sensitivity, Specificity and Number of Tests on Prevalence Ratio Estimation,"
IJERPH, MDPI, vol. 17(15), pages 1-21, July.
Handle:
RePEc:gam:jijerp:v:17:y:2020:i:15:p:5328-:d:389075
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:17:y:2020:i:15:p:5328-:d:389075. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.